Neurodiagnostics Market Overview, Competitive Analysis and Forecast 2031

Comments · 112 Views

The Neurodiagnostics Market in 2023 is US$ 8.01 billion, and is expected to reach US$ 13.99 billion by 2031 at a CAGR of 7.22%.

The Neurodiagnostics Market in 2023 is US$ 8.01 billion, and is expected to reach US$ 13.99 billion by 2031 at a CAGR of 7.22%.

FutureWise Research published a report that analyzes Neurodiagnostics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Neurodiagnostics research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Neurodiagnostics Market Sample

 

Neurodiagnostics Market Segmentation:

By Product

·            Diagnostic and Imaging Systems

·             Electroencephalogram (EEG) Systems

·             Electromyography (EMG) Products

·             Magnetic Resonance Imaging (MRI) Systems

·             Ultrasound Imaging Systems

·             Computed Tomography (CT) Scanner

·             Magnetoencephalogram (MEG) System

·             Position emission tomography (PET) System

·             Angiography System

·             Other Systems

·        Clinical Testing Instruments

·             PCR

·             Next-Generation Sequencing (NGS)

·             Sanger Sequencing

·             Other Clinical Diagnostic Products

·        Reagents & Consumables

·             Media and Serra

·             Solvents

·             Enzymes, Protein & Peptides

·             Probes

·             Buffers

·             Antibodies

·             Other Reagents

 By Disease Pathology

·        Neuro Degenerative Diseases

·        Epilepsy

·        Stroke

·        Headache Disorders

·        Sleep Disorders

·        Other Diseases

By End User

·        Hospitals and Surgery Centers

·        Neurology Centers

·        Ambulatory Care Centers

·        Diagnostic Laboratories & Imaging Centers

·        Research Laboratories & Academic Institutes

By Region

·        North America

·        Latin America

·        Europe

·        Asia-Pacific

·        Middle East and Africa

 

Major players included in the Neurodiagnostics Market are:

·        GE Healthcare

·        Siemens Healthineers

·        Philips Healthcare

·        Canon, Inc.

·        Hitachi, Ltd.

·        Lifelines Neuro Company, LLC

·        Natus Medical Incorporated

·        Hoffman-La Roche AG

·        FUJIFILM Holdings Corporation

·        Mitsar Co., Ltd.

·        Advanced Brain Monitoring

·        Thermo Fisher Scientific, Inc.

·        Bio-Rad Laboratories

·        QIAGEN N.V.

·        Nihon Kohden Corporation

 

Please visit full report of the Neurodiagnostics market @ Visit Neurodiagnostics Market

Competitive Landscape:

·         Tier one players - market players with a significant share of the market

·         Tier two players

·         Players with rapid growth

·         New Entries

 

FutureWise Key Takeaways:

Comments